$PRPO

Precipio Inc (PRPO) (Q2 2026) Earnings Call Highlights: Record Revenue and Positive EBITDA

Precipio Inc (PRPO) reported record Q2 2026 revenue of $7M, up 22% YoY. Adjusted EBITDA turned positive at $400K, driven by revenue growth and lower stock-based compensation. The company added new distributor reps and expects pipeline conversions to boost growth. CEO Ilan Danieli highlighted the 'flywheel' model's competitive advantage and the market potential of the AML product.

Original reporting
Published Aug 21, 2026, 3:30 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 21, 2026, 4:13 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Precipio Inc (PRPO) (Q2 2026) Earnings Call Highlights: Record Revenue and Positive EBITDA — source image
Decision brief

The 30-second read

$PRPOBullishMed
01

Why it matters

The company achieved record revenue and turned EBITDA positive, suggesting operational leverage and cash generation.

02

Market read

Micro‑cap earnings with positive surprise may drive short‑term price movement.

03

What to watch

High trading volume and algorithmic activity could increase volatility regardless of fundamentals.

Relevance 6/10Novelty 6/10Timing: post‑earnings release

Background

Precipio Inc (PRPO) held its Q2 2026 earnings call, presenting its first quarterly results for the period.

Company-level read

Ticker impact

$PRPOBullishMedium confidence
Context

Precipio reported record Q2 revenue of $7M, positive adjusted EBITDA of $0.4M and $700K operating cash flow, the first earnings disclosure for the quarter.

Expected impact

Potential modest price rise on post‑earnings momentum.

Evidence & confidence

Micro‑cap earnings surprise can move the stock, but limited liquidity caps magnitude.

Market effects

Highlights growth potential in the diagnostic pathology market.

U.S. micro‑cap healthcare segment may see increased investor interest.

Limited to niche diagnostic sector; no broad market effect.

Counterpoint

Given the small scale, the earnings beat may be priced in quickly, limiting upside.

Key entities

  • Ilan Danieli

    CEO of Precipio who provided the earnings commentary.

Related articles

$PRPOMedAI 8/10

Precipio, Inc. Q2 2026 Earnings: Revenue Beats $7.02 Million Record

Precipio (NASDAQ: PRPO) reported Q2 2026 GAAP EPS of -$0.12 and a GAAP net loss of $0.219 million, alongside record net sales of $7.02 million, up about 24% year over year. Revenue beat the cited consensus $1.68 million. Product revenue rose to $0.906 million and adjusted EBITDA was $0.4 million. Cash at quarter-end was $3.08 million.

$PRPOMed

Precipio, Inc. (PRPO): Results of Operations and Financial Condition

Precipio, Inc. (PRPO) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Precipio Announces Q2-2026 Financial Results Revenue reaches quarterly record as Precipio returns to positive Adjusted EBITDA and strengthens cash position NEW HAVEN, CT, Globenewswire – (Aug 14, 2026) - Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PR

$PRPOMed

Precipio (NASDAQ:PRPO) Stock Price Crosses Below 200

Precipio Inc. (NASDAQ:PRPO) shares fell below their 200-day moving average during Wednesday trading, trading as low as $23.44 and last at $23.55. The 200-day average is $25.08. The article cites recent analyst changes, including a downgrade to “hold” by Wall Street Zen and “sell” ratings from Weiss. Precipio reported May 14 quarterly EPS of ($0.81) on $6.71M revenue.

$PLBLMed

Polibeli Group Ltd (PLBL): Financial results for H1 2026

Polibeli Group Ltd (PLBL) furnished an SEC Form 6-K — earnings release. Polibeli Group Ltd Announces Unaudited Financial Results for the six months ended June 30, 2026 On September 21, 2026, Polibeli Group Ltd (the “Company”) announced its unaudited financial results for the six months ended June 30, 2026. Business and Strategic Update ● As of the da

$VICRHighAI 8/10

Why is Vicor stock surging today?

Vicor Corporation's stock rose 12.3% after hours after raising its Q3 2026 revenue growth guidance from nearly 10% to over 20%, driven by royalties from its VPD licensing program. Four major companies have licensed the technology, and the CEO noted potential supply disruptions for unlicensed suppliers. The company also recently authorized a $150M share buyback and acquired properties for AI-driven demand. The Nasdaq closed at a record high, led by AI stocks, but broader indices were unchanged.

$OPTULow

Optimum Communications, Inc. (OPTU): Results of Operations and Financial Condition

Optimum Communications, Inc. (OPTU) filed an SEC Form 8-K — Results of Operations and Financial Condition. Item 2.02 Results of Operations and Financial Condition. The information appearing below under Item 4.02 regarding certain previously reported financial information of Optimum Communications, Inc. (the "Company") for the fiscal year ended December 31, 2025, and the fiscal quarter